A detailed history of Robertson Stephens Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 5,571 shares of LLY stock, worth $4.17 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,571
Previous 5,502 1.25%
Holding current value
$4.17 Million
Previous $4.98 Million 0.92%
% of portfolio
0.18%
Previous 0.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $53,277 - $66,241
69 Added 1.25%
5,571 $4.94 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $355,911 - $446,338
491 Added 9.8%
5,502 $4.98 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $512,845 - $686,114
866 Added 20.89%
5,011 $3.9 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $509,959 - $601,175
971 Added 30.59%
4,145 $2.42 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $258,211 - $355,984
594 Added 23.02%
3,174 $1.7 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $114,691 - $153,356
-327 Reduced 11.25%
2,580 $1.21 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $118,039 - $138,631
380 Added 15.04%
2,907 $998,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $362,708 - $422,627
-1,128 Reduced 30.86%
2,527 $924,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $118,592 - $135,148
-400 Reduced 9.86%
3,655 $1.18 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $576,134 - $676,467
-2,067 Reduced 33.76%
4,055 $1.31 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $408,595 - $507,780
1,741 Added 39.74%
6,122 $1.75 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $774,608 - $961,292
3,445 Added 368.06%
4,381 $1.21 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $207,417 - $255,256
936 New
936 $216,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Robertson Stephens Wealth Management, LLC Portfolio

Follow Robertson Stephens Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.